Flavonoids inhibit angiogenic cytokine production by human glioma cells

Phytotherapy Research

Volumn 25, Issue 6, 2011, Pages 916-921

  Freitas, Sandra ^a   Costa, Silvia ^a   Azevedo, Camila ^a   Carvalho, Gerson ^a   Freire, Songeli ^a   Barbosa, Pedro ^a   Velozo, Eudes ^a   Schaer, Robert ^a   Tardy, Marcienne ^b   Meyer, Roberto ^a   Nascimento, Ivana ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

angiogenesis; angiogenic factor inhibitors; flavonoids; glioblastoma; TGF 1; VEGF

Indexed keywords

5 HYDROXY 7,4' DIMETHOXYFLAVONE; APIGENIN; BEVACIZUMAB; CASTICIN; FLAVONOID; PENDULETIN; RUTOSIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROTON BETULASTER; CYTOKINE PRODUCTION; DIMORPHANDRA MOLLIS; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; PROTEIN SECRETION;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CROTON; CYTOKINES; FABACEAE; FLAVONOIDS; GLIOBLASTOMA; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PHYTOTHERAPY; PLANT EXTRACTS;

DIMORPHANDRA MOLLIS;

EID: 79957875674     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3338     Document Type: Article

References (42)

1. Barbosa PR, Fascio M, Martins D, Guedes MLS, Roque NF,. 2003. Triterpenes of Croton betulaster (Euphorbiaceae). Biochem Systemat Ecol 31: 307-308. (Pubitemid 36260986)
2. Barbosa PR, Martins D, Roque NF, Guedes MLS, Fascio M,. 2000. Triterpeno e flavonõides das folhas de Croton betulaster (Euphorbiaceae). In 22nd International Symposium on the Chemistry of Natural Products IUPAC: São Carlos, Brazil.
3. Bierie B, Moses HL,. 2006. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520. (Pubitemid 43980540)
4. Boudet AM., 2007. Evolution and current status of research in phenolic compounds. Phytochemistry 68: 2722-2735.
5. Cheng D, Lee YC, Rogers JT, et al. 2000. Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions. Chest 118: 1747-1753. (Pubitemid 32001805)
6. Chow NH, Liu HS, Chan SH, Cheng HL, Tzai TS,. 1999. Expression of vascular endothelial growth factor in primary superficial bladder cancer. Anticancer Res 19 (5C): 4593-4597.
7. Cordeiro I., 1995. Euphobiaceae. In Flora of the Pico das Almas, Stannard BL, Harvey YB, Harley RM, (eds). Chapada Diamantina: Bahia, Brazil; 303.
8. Costa S, Silva AR, Pinheiro A, et al. 2008. The flavonoid rutin induces astrocyte and microglia activation and regulates TNF-alpha and NO release in primary glial cell cultures. Cell Biol Toxicol 24: 75-89.
9. Csupor-Löffler B, Hajdú Z, Zupkõ I, et al. 2008. Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s.l. on cultured human tumour cell lines. Phytother Res 23: 672-676.
10. Dvorak HF, Brown LF, Detmar M, Dvorak AM,. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146: 1029-1039.
11. Fang J, Zhou Q, Liu LZ, et al. 2007. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis 28: 858-864. (Pubitemid 46523341)
12. Farhadi MR, Capelle HH, Erber R, Ullrich A, Vajkoczy P,. 2005. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas. J Neurosurg 102: 363-370. (Pubitemid 43194089)
13. Ferrara N., 2001. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280: C1358-C1366. (Pubitemid 32553190)
14. Ferrara N, Davis-Smyth T., 1997. The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25. (Pubitemid 27076453)
15. Ferrara N, Henzel WJ,. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858. (Pubitemid 19162712)
16. Ferrari G, Pintucci G, Seghezzi G, Hymann K, Galloway AC, Mignatti P,. 2006. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA 14; 103 (46): 17260-17265. (Pubitemid 44788957)
17. Folkman J., 1985. Tumor angiogenesis. Adv Cancer Res 43: 175-203.
18. Folkman J., 1995. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763.
19. Gordinier ME, Zhang HZ, Patenia R, et al. 1999. Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma. Clin Cancer Res 5: 2498-2505. (Pubitemid 29437334)
20. Haïdara K, Zamir L, Shi QW, Batist G,. 2006. The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett 242: 180-190. (Pubitemid 44485312)
21. Hajdú Z, Hohmann J, Forgo P, et al. 2007. Diterpenoids and flavonoids from the fruits of Vitex agnus-castus and antioxidant activity of the fruit extracts and their constituents. Phytother Res 21: 391-394. (Pubitemid 46595988)
22. Han X, Ma X, Zhang T, Zhang Y, Liu Q, Ito Y,. 2007. Isolation of high-purity casticin from Artemisia annua L. by high-speed counter-current chromatography. J Chromatogr A 1151: 180-182. (Pubitemid 46679018)
23. Hanahan D, Folkman J,. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364. (Pubitemid 26272076)
24. Ivanović V, Todorović-Raković N, Demajo M, et al. 2003. Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression. Eur J Cancer 39: 454-461. (Pubitemid 36173689)
25. Kuo SM, Morehouse HF, Lin CP,. 1997. Effect of antiproliferative flavonoids on ascorbic acid accumulation in human colon adenocarcinoma cells. Cancer Lett 116: 131-137.
26. Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R., 1999. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res 59: 622-632. (Pubitemid 29076060)
27. Li WX, Cui CB, Cai B, Wang HY, Yao XS,. 2005. Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells. J Asian Nat Prod Res 7: 615-626. (Pubitemid 40909330)
28. Lorenzi H., 1949. Botanical aspects. In Úrvores Brasileiras: Manual de Identificação e Cultivo de Plantas Arbõreas Nativas do Brasil. Plantarum: Rio de Janeiro, 2-175.
29. Martinez-Florez S, Gonzallez-Gallego J, Culebras JM, Tuñon MJ., 2002. Los flavonõides: propiedades y acciones antioxidantes. Nutrition Hosp XVII: 271-278. (Pubitemid 44616129)
30. Mesiano S, Ferrara N, Jaffe RB,. 1998. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J Pathol 153: 1249-1256. (Pubitemid 28465848)
31. Noonan DM, Benelli R, Albini A,. 2007. Angiogenesis and cancer prevention: a vision. Rec Res Cancer Res 174: 219-224.
32. Oft M, Heider KH, Beug H,. 1998. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8: 1243-1252. (Pubitemid 28540052)
33. Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P, Ribatti, D., 2006. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem 13: 1845-1857.
34. Salven P, Heikkila P, Anttonen A, Kajanti M, Joensuu H,. 1997. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 10: 1128-1133. (Pubitemid 27521291)
35. Scheck A, Perry K, Hank N, Clark W,. 2006. Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells. BMC Complement Altern Med 6: 27.
36. Schindler R, Mentlein R,. 2006. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr 136: 1477-1482. (Pubitemid 43765348)
37. Schultz A., 1984. Botanical aspects. In Introdução à Botânica Sistemática, Editora da Universidade: Porto Alegre, 4-165.
38. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF,. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (4587): 983-985.
39. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T,. 1997. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15: 826-832. (Pubitemid 27074254)
40. Vinals F, Pouyssegur J,. 2001. Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol 21: 7218-7230. (Pubitemid 32953476)
41. Wick W, Naumann U, Weller M,. 2006. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12: 341-349.
42. Xiong B, Gong LL, Zhang F, Hu MB, Yuan HY,. 2002. TGF beta1 expression and angiogenesis in colorectal cancer tissue. World J Gastroenterol 8: 496-498. (Pubitemid 34692750)